These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The global drug gap. Reich MR Science; 2000 Mar; 287(5460):1979-81. PubMed ID: 10755953 [TBL] [Abstract][Full Text] [Related]
5. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues. Schuklenk U Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958 [No Abstract] [Full Text] [Related]
6. Facilitating access of AIDS drugs while maintaining strong patent protection. Ziker D Duke Law Technol Rev; 2001 Dec; ():E1. PubMed ID: 15709282 [TBL] [Abstract][Full Text] [Related]
7. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro. Resnik DB; DeVille KA Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852 [No Abstract] [Full Text] [Related]
8. Drug research. WHO panel weighs radical ideas. Enserink M Science; 2006 Dec; 314(5804):1373. PubMed ID: 17138875 [No Abstract] [Full Text] [Related]
9. International patent protection for HIV-related therapies: patent attorney's perspective. Pavento LC; Greene JL; McDonald JK Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935 [No Abstract] [Full Text] [Related]
10. India's pharmaceutical industry: hype or high tech take-off? Malhotra P; Lofgren H Aust Health Rev; 2004 Nov; 28(2):182-93. PubMed ID: 15527398 [TBL] [Abstract][Full Text] [Related]
11. Patent buy-outs for global disease innovations for low- and middle-income countries. Outterson K Am J Law Med; 2006; 32(2-3):159-73. PubMed ID: 16927608 [No Abstract] [Full Text] [Related]
12. The distribution of biomedical research resources and international justice. Resnik DB Dev World Bioeth; 2004 May; 4(1):42-57. PubMed ID: 15086373 [TBL] [Abstract][Full Text] [Related]
13. The Constant Gardener revisited: the effect of social blackmail on the marketing concept, innovation, and entrepreneurship. Miles MP; Munilla LS; Covin JG J Bus Ethics; 2002 Dec; 41(3):287-95. PubMed ID: 12755097 [TBL] [Abstract][Full Text] [Related]
14. Patents, ethics and improving healthcare. Poste G; Roberts D; Gentry S Bull Med Ethics; 1997 Jan; No. 124():29-31. PubMed ID: 11655056 [No Abstract] [Full Text] [Related]
15. Ethics and AIDS drugs: some countries want to suspend patent and trade laws to get lower-cost medications to the poor. Dowell W Time; 1999 Jul; 152(4):49. PubMed ID: 11657653 [No Abstract] [Full Text] [Related]
16. Narrowing the gap. Bayley A J Med Ethics; 2000 Feb; 26(1):51-3. PubMed ID: 11645201 [No Abstract] [Full Text] [Related]
17. Introduction: ethical responsibilities regarding drugs, patents, and health. Ryan MP Bus Ethics Q; 2005 Oct; 15(4):543-7. PubMed ID: 16358441 [No Abstract] [Full Text] [Related]
18. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective. Viana JM Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298 [No Abstract] [Full Text] [Related]
19. Sparks fly over patents and vital drugs at world health assembly. Kapp C Lancet; 2003 May; 361(9372):1873. PubMed ID: 12788578 [No Abstract] [Full Text] [Related]
20. Compulsory licensure: the case of Cipro and beyond. Chakrabarty AM Am J Bioeth; 2002; 2(3):40. PubMed ID: 12230853 [No Abstract] [Full Text] [Related] [Next] [New Search]